The Quiet Revolution in Sleep Diagnostics: Onera and Somnoware's New Alliance

EINDHOVEN, NETHERLANDS – June 15, 2026 – A significant, yet deceptively simple, software integration is poised to fundamentally reshape the landscape of sleep medicine. Onera Health, a Dutch innovator in sleep diagnostics, has announced that its home polysomnography (hPSG) solution will now seamlessly integrate with Somnoware by ResMed, a leading sleep lab management platform. While a software handshake might not seem revolutionary, this move represents a critical piece of operational innovation aimed at solving one of healthcare's most persistent bottlenecks: the diagnosis of sleep disorders.

The collaboration enables clinicians to manage gold-standard Polysomnography (PSG) tests—the comprehensive studies traditionally confined to specialized labs—from a patient's own home, with the entire workflow contained within the familiar Somnoware interface. This is more than a convenience; it's a strategic assault on the long wait times, high costs, and operational complexities that have left millions of potential sleep disorder sufferers undiagnosed and untreated.

Unlocking the Clinical Workflow

For sleep clinics, the daily reality is often a logistical tangle of disparate systems and manual processes. The announcement directly targets this pain point. The integration of Onera’s cloud-based hPSG® platform with Somnoware eliminates the need for clinicians to juggle multiple software programs or manually transfer massive data files from a home test into their central management system. Once a patient completes an Onera study at home, the results are automatically and immediately available within Somnoware for review, scoring, and interpretation.

“The integration with Somnoware is a welcomed enhancement that broadens access to the Onera hPSG® solution,” stated Ruben de Francisco, Founder and CEO of Onera Health, in the company’s announcement. “Many sleep centers are customers of both Onera and Somnoware. We are very pleased that the integration of our cloud-based platforms will enable clinicians to benefit from a streamlined clinical workflow.”

This streamlined workflow is the core of the operational innovation. Somnoware, which was acquired by sleep market giant ResMed, has built its reputation as a powerful data orchestrator. The platform is designed to pull data from over 20 different medical devices, integrating with Electronic Medical Record (EMR) systems to create a unified patient view. By bringing Onera's comprehensive sleep data directly into this ecosystem, the partnership creates a powerful, end-to-end diagnostic pathway. A sleep technologist can now manage scheduling, send the patient home with Onera's user-friendly patch-based system, and see the complete study data populate in the patient's file the next morning, ready for the physician’s review. This efficiency can translate into more patients being diagnosed per week, optimizing the use of limited and expensive clinical resources.

“Previously, managing data from various home and in-lab devices was a significant administrative burden,” noted one sleep clinic director familiar with the new workflow. “This type of direct, automated integration allows my team to focus less on data logistics and more on patient care and accurate interpretation, which is where our value truly lies.”

From the Unfamiliar Lab to the Comfort of Home

The most profound impact of this partnership will be felt by patients. The traditional in-lab PSG, while considered the diagnostic gold standard, is notoriously burdensome. Patients often face wait times exceeding six months for an appointment, must travel to a facility, and attempt to sleep in an unfamiliar environment while connected to a web of wires and sensors. This experience can be so daunting that it contributes to high patient dropout rates before a diagnosis is even made. Furthermore, the artificial lab setting can fail to capture a true representation of a patient's typical night of sleep.

Home Sleep Apnea Tests (HSATs) have offered a more convenient alternative, but they come with a significant trade-off. Most HSATs are limited in scope, primarily screening for Obstructive Sleep Apnea (OSA) by measuring breathing, heart rate, and oxygen levels. They typically lack the electroencephalogram (EEG) sensors needed to measure brain waves, making them incapable of determining sleep stages or diagnosing non-respiratory sleep disorders like periodic limb movement disorder or certain parasomnias.

Onera’s hPSG® solution bridges this critical gap. The company received FDA 510(k) clearance in 2022 for its patch-based, wireless system that provides data comparable to an in-lab PSG, including EEG, EOG (eye movements), EMG (muscle activity), and ECG (heart activity). By bringing this comprehensive level of testing into the patient's home, the Onera-Somnoware integration democratizes access to gold-standard diagnostics. It offers the accuracy of a lab study with the convenience of a home test, potentially leading to faster, more accurate diagnoses and a clearer path to treatment for a wider range of conditions beyond just OSA.

A Strategic Alliance in a Shifting Market

The business rationale behind this integration is as compelling as its clinical benefits. It represents a powerful strategic synergy between an agile innovator and an established market leader. Onera Health gains access to the vast network of sleep clinics already embedded in the Somnoware ecosystem, significantly lowering the barrier to adoption for its cutting-edge hardware. For ResMed's Somnoware, the integration enriches its platform, making it an even more indispensable hub for modern sleep clinics that are increasingly adopting a hybrid model of in-lab and at-home testing.

This move also places competitive pressure on other players in the sleep diagnostics market, such as Philips and Natus. By creating a seamless, end-to-end solution for comprehensive home sleep testing, Onera and ResMed are setting a new standard for workflow efficiency. Competitors will now be measured not just by the quality of their standalone devices, but by the strength of their integrated software ecosystem. As reimbursement policies from both government payers like CMS and private insurers continue to evolve in favor of effective and efficient home-based diagnostics, solutions that reduce friction and improve outcomes are positioned for long-term success.

Ultimately, this partnership is more than a product update; it's a reflection of the broader shift in healthcare toward decentralized, patient-centric care. By leveraging cloud technology to connect a sophisticated home diagnostic tool with a powerful clinical management platform, Onera and Somnoware are not just improving a process—they are building a more scalable and accessible model for the future of sleep medicine.